$\require{mediawiki-texvc}$
  • 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색도움말
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"

통합검색

도움말도움말
상세검색 다국어 입력

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

특허 상세정보

MyON담기
내보내기 페이스북 공유 카카오톡 공유

Reagents and method employing channeling

특허상세정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판) C12Q-001/66   
미국특허분류(USC) 435/7 ; 23/230B ; 424/7 ; 424/12
출원번호 US-0893650 (1978-04-05)
발명자 / 주소
  • Maggio Edward T. (Redwood City CA) Wife Richard L. (Sittingbourne CA GB2) Ullman Edwin F. (Atherton CA)
출원인 / 주소
  • Syva Company (Palo Alto CA 02)
인용정보 피인용 횟수 : 153  인용 특허 : 2
초록
▼

Method and compositions are provided for chemical analysis of an analyte which is a member of a specific binding pair of organic substances consisting of ligand and ligand receptor (antiligand). The method involves bringing together the following reagents with the analyte in an aqueous assay medium under mild conditions. The first reagent is a conjugate of a member of the specific binding pair with a chemical entity which provides a means for chemically changing the concentration of a compound which acts as a signal mediator. The second reagent is the si...

대표
청구항
▼

A method for determining the presence of an analyte in a sample suspected of containing said analyte, said analyte being a member of a specific binding pair consisting of ligand and antiligand, wherein the amount of a detectable signal is a function of the amount of analyte in an assay medium, said detectable signal being produced by having three primary reagents: (A) reactant label conjugate consisting of a reactive organic compound conjugated to a member of said specific binding pair which interacts with a signal mediator precursor to produce a signal ...

이 특허에 인용된 특허 (2)

  1. Cohen ; Richard J. ; Benedek ; George B., Immunoassay by light scattering spectroscopy.
  2. Maier ; Jr. ; Charles L., Procedure for the assay of pharmacologically immunologically and biochemically active compounds in biological fluids.

이 특허를 인용한 특허 (153)

  1. Ruddell, Carolyn Jennifer; Allen, Gerald John; Evans, Douglas Robert; Burke, Elizabeth, Agglutination assay.
  2. DiNello Robert K. (Cupertino CA), Agglutination dependent enzyme channeling immunoassay.
  3. Sommer, Ronald G., Analytical element and method for preventing reagent migration.
  4. Buechler Kenneth F. ; Valkirs Gunars E., Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays.
  5. Harvey, Jeanne; Singh, Sharat; Kim, Phillip; Liu, Xinjun; Barham, Robert; Liu, Limin, Antibody-based arrays for detecting multiple signal transducers in rare circulating cells.
  6. Harvey, Jeanne; Singh, Sharat; Kim, Phillip; Liu, Xinjun; Barham, Robert; Liu, Limin, Antibody-based arrays for detecting multiple signal transducers in rare circulating cells.
  7. Harvey, Jeanne; Singh, Sharat; Kim, Phillip; Liu, Xinjun; Barham, Robert; Liu, Limin, Antibody-based arrays for detecting multiple signal transducers in rate circulating cells.
  8. Chen, Horng H.; Burnett, Jr., John C., Aquaretic and natriuretic polypeptides lacking vasodilatory activity.
  9. Chandler Howard M.,CAX, Assay device.
  10. Self Colin H. (46 Lensfield Road Cambridge GBX), Assay method and reagent therefor.
  11. Edwin F. Ullman ; Hrair Kirakossian ; John S. Pease ; Yuri Daniloff ; Daniel B. Wagner, Assay method utilizing induced luminescence.
  12. Ullman Edwin F. ; Kirakossian Hrair ; Pease John S. ; Daniloff Yuri ; Wagner Daniel B., Assay method utilizing induced luminescence.
  13. Chen, Lieping; Strome, Scott E.; Kwon, Eugene D., B7-H1 and methods of diagnosis, prognosis, and treatment of cancer.
  14. Chen, Lieping, B7-H1 antibodies and method of use.
  15. Chen, Lieping, B7-H3 and B7-H4, novel immunoregulatory molecules.
  16. Kwon, Eugene D.; Cheville, John, B7-H4 expression on tumor vasculature.
  17. Langermann, Solomon; Liu, Linda; Podojil, Joseph R.; Miller, Stephen D.; Marshall, Shannon, B7-H4 fusion proteins and methods of use thereof.
  18. Ruegg, Curzio; Monnier-Benoit, Sylvain; Ciarloni, Laura; Therianos, Stavros, Biomarker combinations for colorectal cancer.
  19. Rajendra Singh ; Gregory Gorski ; Gary Frenzel, Bridged fluorescent dyes, their preparation and their use in assays.
  20. Bersot, Ross; Humphries, Paul, Carbazole-containing amides, carbamates, and ureas as cryptochrome modulators.
  21. Bersot, Ross; Humphries, Paul, Carbazole-containing amides, carbamates, and ureas as cryptochrome modulators.
  22. Bersot, Ross; Humphries, Paul, Carbazole-containing sulfonamides as cryptochrome modulators.
  23. Bersot, Ross; Humphries, Paul, Carbazole-containing sulfonamides as cryptochrome modulators.
  24. Harris Curtis C. (8402 Thornden Ter. Bethesda MD 20034), Cascade amplification enzyme immunoassay.
  25. Ullman Edwin F. ; Singh Sharat, Chemiluminescent compositions and their use in the detection of hydrogen peroxide.
  26. Chen, Horng H.; Burnett, Jr., John C., Chimeric aquaretic and natriuretic polypeptides lacking vasodilatory activity.
  27. Chen, Horng H.; Burnett, Jr., John C., Chimeric aquaretic and natriuretic polypeptides lacking vasodilatory activity.
  28. Dickey, Deborah; Burnett, Jr., John C.; Potter, Lincoln R., Chimeric natriuretic peptides without hypotensive inducing capability.
  29. Burnett, Jr., John C.; Lee, Candace Y. W., Chimeric natriuretic polypeptides with unique pharmacologic profiles.
  30. Nagakawa, Kenji; Tsujimoto, Tomomichi; Nishino, Susumu; Teramoto, Masaaki; Kawase, Yoshiyuki, Colorimetric method and reagent used for the same.
  31. Nagakawa, Kenji; Tsujimoto, Tomomichi; Nishino, Susumu; Teramoto, Masaaki; Kawase, Yoshiyuki, Colorimetric method and reagent used for the same.
  32. Giannini Ivo (Rome ITX) Baroncelli Vittorio (Rome ITX), Composition suitable for testing biological tissues and/or liquids, and the method of use.
  33. Giannini Ivo (Rome ITX) Baroncelli Vittorio (Rome ITX), Composition suitable for testing biological tissues and/or liquids, and the method of use.
  34. Bermudes, David Gordon, Compositions and methods for determining successful immunization by one or more vaccines.
  35. Cheever, Martin A.; Disis, Mary L., Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated.
  36. Cheever, Martin A; Disis, Mary L, Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated.
  37. Cheever, Martin A; Disis, Mary L, Compounds for eliciting or enhancing immune reactivity to HER-2/protein for prevention or treatment of malignancies in which the HER-2/oncogene is associated.
  38. Tom Henry K. (La Honda CA) Rowley Gerald L. (Cupertino CA), Concentrating zone method in heterogeneous immunoassays.
  39. Chen, Lieping; Strome, Scott E.; Kwon, Eugene D., Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target.
  40. Chen, Lieping, Detection and diagnosis of inflammatory disorders.
  41. Skold Carl N. (Mountain View CA) Shanafelt Armen B. (Redwood City CA) Ghazarossian Vartan (Menlo Park CA) Ullman Edwin F. (Atherton CA), Device for immunochromatographic analysis.
  42. Blatt Joel M. ; Mangan Wilma M. ; Patel Paul J. ; Manneh Victor A., Device for preventing assay interference using silver or lead to remove the interferant.
  43. Urdea, Michael S.; McKenna, Michael P.; Arensdorf, Patrick A., Diabetes-related biomarkers and methods of use thereof.
  44. Urdea, Michael S.; McKenna, Michael P.; Arensdorf, Patrick A., Diabetes-related biomarkers and methods of use thereof.
  45. Urdea, Michael S.; McKenna, Michael P.; Arensdorf, Patrick A., Diabetes-related biomarkers and methods of use thereof.
  46. Marlborough, David Ian; Sloane, Andrew John; Cole, Robert Alan; Hunter, William Samuel, Diagnostic testing process.
  47. Simari, Robert D.; Pan, Shuchong; Burnett, Jr., John C.; Chen, Horng H., Diuretic and natriuretic polypeptides lacking the blood pressure lowering property.
  48. Singh, Sharat; Harvey, Jeanne; Kim, Phillip; Liu, Xinjun; Liu, Limin; Barham, Robert; Neri, Bruce, Drug selection for breast cancer therapy using antibody-based arrays.
  49. Singh, Sharat; Harvey, Jeanne; Kim, Phillip; Liu, Xinjun; Liu, Limin; Barham, Robert; Neri, Bruce, Drug selection for breast cancer therapy using antibody-based arrays.
  50. Singh, Sharat; Harvey, Jeanne; Kim, Phillip; Liu, Xinjun; Liu, Limin; Barham, Robert; Neri, Bruce, Drug selection for breast cancer therapy using antibody-based arrays.
  51. Kim, Phillip; Singh, Sharat, Drug selection for colorectal cancer therapy using receptor tyrosine kinase profiling.
  52. Singh, Sharat; Harvey, Jeanne, Drug selection for lung cancer therapy using antibody-based arrays.
  53. Blatt, Joel M.; Allen, Michael P., Dry reagent particle assay and device having multiple test zones and method therefor.
  54. DiNello Robert K. (Cupertino CA) Gibbons Ian (Palo Alto CA) Ullman Edwin F. (Atherton CA), Enzymatic poly-reactant channeling binding assay.
  55. Giese Roger W. (Quincy MA) Ehrat Markus (Suhr MA CHX) Cecchini Douglas J. (Somerville MA), Enzyme activity amplification method for increasing assay sensitivity.
  56. Miron, Alexander; Iglehart, James Dirk; Harris, Lyndsay N.; Lu, Xin; Shi, Qian, Fibrinogen alpha and hemoglobin polypeptides as cancer markers.
  57. Kido,Horacio; Norton,James R.; Coombs,James H., Fluidic circuits for sample preparation including bio-discs and methods relating thereto.
  58. Lippa Arnold S. (Franklin Lakes NJ), Fluorescence immunoassay involving energy transfer between two fluorophores.
  59. Weng Litai (Mountain View CA) Gibbons Ian (Palo Alto CA) Ullman Edwin F. (Atherton CA), Homogeneous enzyme specific binding assay on non-porous surface.
  60. Cheever Martin A. ; Disis Mary L., Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is a.
  61. Cheever Martin A. ; Disis Mary L., Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is a.
  62. Cheever Martin A. ; Disis Mary L., Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated.
  63. Cheever, Martin A.; Disis, Mary L., Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated.
  64. Cheever,Martin A; Disis,Mary L, Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated.
  65. Cheever Martin A. ; Disis Mary L., Immune reactivity to HER-2/neu protein for diagnosis of malignancies in which the HER-2/neu oncogene is associated.
  66. Cheever, Martin A; Disis, Mary L, Immune reactivity to HER-2/protein for diagnosis and treatment of malignancies in which the HER-2/oncogene is associated.
  67. Self Colin H. (46 Lensfield Rd. Cambridge CB2 1EG GB2), Immunoassay using an amplified cyclic detection system.
  68. Self Colin H. (46 Lensfield Road Cambridge CB2 1EG GBX), Immunoassay with an increasing cyclic detection system.
  69. Baldwin Thomas O. (Bryan TX) Holzman Thomas F. (Bryan TX) Satoh Paul S. (Portage MI) Yein Frederick S. (Kalamazoo MI), Immunoassays with luciferase labeled ligands or receptors.
  70. Chandler Howard M. ; Piasio Roger N. ; Prouty Karen, Immunochromatographic assay device.
  71. David Gary S. (La Jolla CA) Greene Howard E. (Carlsbad CA), Immunometric assays using monoclonal antibodies.
  72. Pan, Shuchong; Simari, Robert D., Isoforms of brain natriuretic peptide.
  73. Litman David J. (Cupertino CA) Harel Zvi (Haifa CA ILX) Ullman Edwin F. (Atherton CA), Macromolecular fluorescent quencher particle in specific receptor assays.
  74. Urdea, Mickey S.; McKenna, Michael P.; Arensdorf, Patrick A., Markers associated with arteriovascular events and methods of use thereof.
  75. Urdea, Mickey S.; McKenna, Michael P.; Arensdorf, Patrick A., Markers associated with arteriovascular events and methods of use thereof.
  76. Sharat Singh ; Edwin F. Ullman, Metal chelate containing compositions for use in chemiluminescent assays.
  77. Singh Sharat ; Ullman Edwin F., Metal chelate containing compositions for use in chemiluminescent assays.
  78. Singh, Sharat; Ullman, Edwin F., Metal chelate containing compositions for use in chemiluminescent assays.
  79. Singh,Sharat; Ullman,Edwin F., Metal chelate containing compositions for use in chemiluminescent assays.
  80. Cole Francis X. (Stow MA) Davis Gene (Lexington MA) Sigillo Eric (Meuthen MA), Metal sol capture immunoassay procedure, kit for use therewith and captured metal containing composite.
  81. Shelburne Charles E. (Brooklyn Park MN), Method and composition for the diagnosis of Lyme disease.
  82. Blatt Joel M. ; Allen Michael P. ; Patel Paul J., Method and device producing a predetermined distribution of detectable change in assays.
  83. Abramson, Jonathan J.; Marinov, Benjamin S., Method for determining redox activity and screening compounds based on redox activity.
  84. Abramson, Jonathan J.; Marinov, Benjamin S., Method for determining redox activity and screening compounds based on redox activity.
  85. McKenna, Michael P.; Rowe, Michael; Moler, Jr., Edward J.; Gerwien, Robert W., Method for determining risk of diabetes.
  86. Pan, Shuchong; Simari, Robert D., Method for increasing natriuresis or diuresis by isoforms of brain natriuretic peptide.
  87. Bacquet, Cathy A.; Twumasi, Daniel Y., Method for ligand determination utilizing an immunoassay monitorable by biotin-containing enzymes, and compositions therefor.
  88. Pease John S. (Los Altos CA) Kirakossian Hrair (San Jose CA) Wagner Daniel B. (Sunnyvale CA) Ullman Edwin F. (Atherton CA), Method of calibration with photoactivatable chemiluminescent matrices.
  89. Burnett, Jr., John C.; Lee, Candace Y. W., Method of increasing natriuretic activity by administering natriuretic polypeptides with unique pharmacologic profiles.
  90. Burnett, Jr., John C.; Olson, Timothy M.; Zingman, Leonid V.; Hodgson-Zingman, Denice Marie, Method of treating cardiac arrhythmia with long acting atrial natriuretic peptide(LA-ANP).
  91. Scarisbrick, Isobel A.; Blaber, Sachiko I.; Blaber, Michael; Rodriguez, Moses, Method of treating multiple sclerosis with anti-K6 antibody.
  92. Burnett, Jr., John C.; Lee, Candace Y. W., Method of treatment of cardiovascular or renal conditions with natriuretic polypeptides with unique pharmacologic profiles.
  93. Simari, Robert D.; Pan, Shuchong; Burnett, Jr., John C.; Chen, Horng H., Method of treatment of renal dysfunctions with chimeric natriuretic peptides.
  94. Hu Mae W. (Sunnyvale CA) Colvin Floyd W. (Redwood City CA) Ullman Edwin F. (Atherton CA), Methods and compositions for assaying for the production of 1,4-dihydropyridyl.
  95. Petrucelli, Leonard; Ash, Peter E.; Gendron, Tania, Methods and materials for detecting C9ORF72 hexanucleotide repeat expansion positive frontotemporal lobar degeneration or C9ORF72 hexanucleotide repeat expansion positive amyotrophic lateral sclerosis.
  96. Dong, Haidong; Kwon, Eugene D.; Markovic, Svetomir N.; Krco, Christopher J., Methods and materials for treating cancer.
  97. Xie,Zongcen Charles; Pierce,Jeffrey A.; Stivers,Carole R., Methods and systems for point of care bodily fluid analysis.
  98. Cheever Martin A. ; Disis Mary L., Methods for eliciting or enhancing reactivity to HER-2/neu protein.
  99. Staples Mark A. ; Haley Carolyn J. ; Parrish Richard F. ; Zmolek Wesley W., Methods for releasing a ligand from a complex.
  100. Dong, Haidong; Harrington, Susan M.; Kwon, Eugene D.; Krco, Christopher J.; Liu, Xin, Methods for treating cancer in patients with elevated levels of BIM.
  101. Livingston, David; Drapkin, Ronny, Methods of detecting ovarian cancer.
  102. Conover,Cheryl A.; Kalli,Kimberly R., Methods of detecting ovarian neoplasia.
  103. Bui, Matthew H. T.; Seligson, David; Belldegrun, Arie S., Methods of renal cell carcinoma prognosis and treatment selection with carbonic anhydrase IX.
  104. Simari, Robert D.; Pan, Shuchong; Burnett, Jr., John C.; Chen, Horng H., Methods of treatment of heart dysfunctions using diuretic and natriuretic polypeptides.
  105. Chen, Horng H.; Burnett, Jr., John C., Methods of treatment using natriuretic polypeptides.
  106. Gordon,John Francis, Multi-parameter assays including analysis discs and methods relating thereto.
  107. Lee,Jin Po, Multiple analyte assay device.
  108. Chandler Howard M.,CAX, Multiple component chromatographic assay device.
  109. Simari, Robert D.; Pan, Shuchong; Burnett, Jr., John C.; Chen, Horng H.; Potter, Lincoln R., Natriuretic peptide receptor-C agonists.
  110. Burnett, Jr., John C.; Lee, Candace Y. W., Natriuretic polypeptides.
  111. Lee, Candace Y. W.; Burnett, Jr., John C., Natriuretic polypeptides.
  112. Lee, Candace Y. W.; Burnett, Jr., John C., Natriuretic polypeptides.
  113. Lee, Candace Y.W.; Burnett, Jr., John C., Natriuretic polypeptides.
  114. Burnett, Jr., John C.; Chen, Horng H.; Lisy, Ondrej, Natriuretic polypeptides for reducing or preventing restenosis.
  115. Burnett, Jr., John C.; Chen, Horng H.; Lisy, Ondrej, Natriuretic polypeptides for reducing restenosis.
  116. Lanzavecchia, Antonio, Neutralizing anti-influenza A virus antibodies and uses thereof.
  117. Lanzavecchia, Antonio, Neutralizing anti-influenza A virus antibodies and uses thereof.
  118. Lanzavecchia, Antonio, Neutralizing anti-influenza A virus antibodies and uses thereof.
  119. Lanzavecchia, Antonio, Neutralizing anti-influenza A virus antibodies and uses thereof.
  120. Buechler Kenneth F. ; Valkirs Gunars E. ; Anderson Richard R., Non-competitive threshold ligand-receptor assays.
  121. Akhavan-Tafti, Hashem, Nonseparation assay methods.
  122. Akhavan-Tafti, Hashem, Nonseparation assay methods.
  123. Akhavan-Tafti, Hashem, Nonseparation assay methods.
  124. Burnett, Jr., John C.; Lee, Candace Y. W., Nucleic acids encoding for chimeric natriuretic polypeptides with unique pharmacologic profiles.
  125. Chandler Howard M.,CAX, Opposable-element assay devices, kits, and methods employing them.
  126. Valencia,Ramoncito Magpantay; Chen,YihFar; Hurt,Susan Newcomb; Urcia,Joseph Roby Iringan; Selvan,Gowri Pyapali, Optical bio-discs and fluidic circuits for analysis of cells and methods relating thereto.
  127. Jorma Virtanen, Optical disk-based assay devices and methods.
  128. Pease John S. ; Kirakossian Hrair ; Wagner Daniel B. ; Ullman Edwin F., Photoactivatable chemiluminescent matrices.
  129. Davalian Dariush (San Jose CA) Singh Rajendra (Mountain View CA) Ullman Edwin F. (Atherton CA), Photoactive indicator compounds.
  130. Rajendra Singh ; Harshvardhan Mehta, Polysaccharide conjugates of biomolecules.
  131. Singh Rajendra ; Mehta Harshvardhan, Polysaccharide conjugates of biomolecules.
  132. Singh, Rajendra; Mehta, Harshvardhan, Polysaccharide conjugates of biomolecules.
  133. Singh, Sharat; Kim, Phillip, Profiling of signal pathway proteins to determine therapeutic efficacy.
  134. McKenna, Michael P.; Watkins, Steve M., Protein and lipid biomarkers providing consistent improvement to the prediction of Type 2 diabetes.
  135. McKenna, Michael P.; Watkins, Steve M., Protein and lipid biomarkers providing consistent improvement to the prediction of type 2 diabetes.
  136. Lin Kuei-Ying ; Matteucci Mark D., Pyrimidine derivatives and oligonucleotides containing same.
  137. Lin,Kuei Ying; Matteucci,Mark D., Pyrimidine derivatives and oligonucleotides containing same.
  138. Kuei-Ying Lin ; Mark D. Matteucci, Pyrimidine derivatives for labeled binding partners.
  139. Lin Kuei-Ying ; Matteucci Mark D., Pyrimidine derivatives for labeled binding partners.
  140. Lin, Kuei-Ying; Matteucci, Mark D., Pyrimidine derivatives for labeled binding partners.
  141. Lin, Kuei-Ying; Matteucci, Mark D., Pyrimidine derivatives for labeled binding partners.
  142. Lin,Kuei Ying; Matteucci,Mark D., Pyrimidine derivatives for labeled binding partners.
  143. Pirio Marcel Rene ; Davalian Dariush ; Ishkanian Jacqueline Sadakan ; Ullman Edwin F., Reagents and methods for specific binding assays.
  144. Staples, Mark A.; Haley, Carolyn J.; Parrish, Richard F.; Zmolek, Wesley W., Reagents for assays for ligands.
  145. Staples Mark A. ; Parrish Richard F., Reagents for assays for mycophenolic acid.
  146. Virtanen Jorma, Spatially addressable, cleavable reflective signal elements, assay device and method.
  147. Virtanen Jorma, Spatially addressable, cleavable reflective signal elements, assay device and method.
  148. Litman David J. (Cupertino CA) Ullman Edwin F. (Atherton CA), Test strip kits in immunoassays and compositions therein.
  149. Buechler Kenneth F. (San Diego CA) Valkirs Gunars E. (Escondido CA) Anderson Richard R. (Encinitas CA), Threshold ligand-receptor assay.
  150. Buechler Kenneth F. (Santee CA) Valkirs Gunars E. (Escondido CA) Anderson Richard R. (Encinitas CA), Threshold ligand-receptor assay.
  151. Ikeda, Yasuhiro; Russell, Stephen James; Cataliotti, Alessandro; Burnett, Jr., John C.; Tonne, Jason M., Treating cardiovascular or renal diseases.
  152. Ikeda, Yasuhiro; Russell, Stephen James; Cataliotti, Alessandro; Burnett, Jr., John C.; Tonne, Jason M., Treating cardiovascular or renal diseases.
  153. Ikeda, Yasuhiro; Russell, Stephen James; Cataliotti, Alessandro; Burnett, Jr., John C.; Tonne, Jason M., Treating cardiovascular or renal diseases.

IPC 상위 출원인